Thermo Fisher Scientific Inc (TMO)

Debt-to-equity ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	49,551,000	48,992,000	47,432,000	45,516,000	46,724,000	45,328,000	43,752,000	42,257,000	43,978,000	43,549,000	42,293,000	40,956,000	40,793,000	38,710,000	36,854,000	35,058,000	34,507,000	31,824,000	29,875,000	28,559,000
Debt-to-equity ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $49,551,000K
= 0.00

Thermo Fisher Scientific Inc has consistently maintained a debt-to-equity ratio of 0.00 across the provided dates from March 31, 2020, to December 31, 2024. A debt-to-equity ratio of 0.00 indicates that the company has no debt or a negligible amount of debt relative to its equity. This signifies that the company relies primarily on equity financing rather than debt to fund its operations and growth. A low or zero debt-to-equity ratio is generally viewed positively by investors and creditors as it implies lower financial risk and greater financial stability for the company. Thermo Fisher Scientific's consistent low debt-to-equity ratio suggests a strong financial position and prudent financial management.